CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 777 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02703038
NCT02703038N/ACompleted

French Observatory on the Management of Cardiogenic Shock in 2016

French Cardiology Society·observational·Posted Mar 9, 2016·Updated Aug 15, 2019

In Brief

An observational study for Shock, Cardiogenic. Completed, enrolled 777 participants across 1 site.

Detailed Summary

Cardiogenic shock (CS) is defined as an organ hypoperfusion secondary to low cardiac output. Catches diagnostic management, and therapeutic monitoring of these patients remain highly variable from one center to another and even from one doctor to another within the same team. The management protocols are often not standardized or non-existent. It appears therefore necessary to make an inventory of the management practices of the CS in France in 2016, prerequisite to a common work of standardization of practices and the creation of specialized networks to support these complex patients.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesFrance
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedMar 9, 2016
Enrollment StartApr 1, 2016
Primary CompletionJul 1, 2018
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 10.3 years ago